Understanding the Genetic
Architecture of Parkinson's Disease

The Global Parkinson’s Genetics Program (GP2) is an ambitious program to genotype >150,000 volunteers around the world to further understand the genetic architecture of Parkinson’s disease (PD). There is still much to learn about genetic risk factors and the path to further understanding requires working collaboratively and openly sharing data, processes, and results.

View Progress

See how many samples are completed and shared with the AMP® PD platform for use.

Learn more

Submit a Cohort

Collaborate with us and submit a cohort to GP2. 

Get Started

GP2 Updates

Check out the latest news about GP2.

More Updates

Request for Information from Researchers of Clinical Studies in the Middle East and North Africa

October 24, 2024
GP2 launches the Middle East and North African (MENA) Request for Information (RFI), which aims to bring together academic researchers located in the Middle East and North Africa to join GP2 and expand our understanding of the genetic basis of Parkinson’s disease.

GP2 Posts Eighth Data Release 

September 18, 2024
GP2 announces its eighth data release which includes 5,481 additional whole genome sequences and 10,454 clinical exome sequences.

GP2 Launches Funded Master's Programs for Underrepresented Populations

June 7, 2024
GP2 is partnering with UCL and UCMB and offers funding for physicians and scientists from underrepresented populations to pursue master's degrees in PD related fields.

Latest Blog Posts

Read the latest blogs from GP2’s scientists and collaborators.

More Blogs

The Components of GP2’s 8th Data Release

September 18, 2024
Overview In September 2024, GP2 announced the eighth data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PD. This release includes 5,481 additional whole genome…

GP2 Bioinformatics Training Workshops and Regional Training Initiatives: Highlighting Global Collaboration

June 26, 2024
The Global Parkinson’s Genetics Program (GP2) continues to spearhead the dissemination of bioinformatics training and clinical knowledge on Parkinson's disease (PD) through a series of training programs worldwide. This post…

The Components of GP2’s Seventh Data Release

April 22, 2024
Overview In April 2024, GP2 announced the seventh data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PD. This release includes >9,000 additional genotyped participants. …

Working Groups

Find out about GP2’s working groups and their recently accomplished milestones.

View More